Uppsala University
International Master's Programme in Innovative Medicine
The Erasmus+ International Master's in Innovative Medicine (IMIM) is a two-year international Master's programme focusing on translational medical research, modern molecular techniques, innovation and entrepreneurship. IMIM is a research-oriented Master's programme, integrated with teaching from associated companies…
- Higher education
- Information unavailable
- 19 August 2026
- Uppsala, Groningen, Heidelberg, Tartu
- Information unavailable
- 100 %
Overview
The Erasmus+ International Master's in Innovative Medicine (IMIM) is a two-year international Master's programme focusing on translational medical research, modern molecular techniques, innovation and entrepreneurship. IMIM is a research-oriented Master's programme, integrated with teaching from associated companies that prepares you for a future global career in interdisciplinary and internationally competitive academic research or the private sector. In the IMIM programme, you will study at two of the four collaborating European universities of Uppsala, Heidelberg, Tartu or Groningen. Further, you will have opportunities to carry out research projects in industry, at affiliated universities in South America, Japan or other universities. The programme comprises in-depth courses including topics such as disease processes, cancer, diagnostics, therapies and methods, and you will be working in multidisciplinary groups designing research applications and business plans. You will get contacts with companies and insights into innovation processes and entrepreneurship. During your studies, you will undertake several research projects, either at a university or at a company. Our graduates have continued to PhD studies at different universities or gotten jobs in Life Science or Pharma companies in many countries. The language of instruction is English.
Admission scores
Entry requirements
The International Master's Programme in Innovative Medicine (IMIM) is a collaboration between Uppsala University (Sweden), the University of Groningen (the Netherlands), Heidelberg University (Germany) and the University of Tartu (Estonia) where admitted students study year 1 at any partner university and year 2 at either Groningen, Uppsala or Tartu. This means that there are four possible study plans where special regulations of admission for IMIM and the involved partner universities must be fulfilled. *Starting at Uppsala University* A Bachelor's degree, equivalent to a Swedish Kandidatexamen, from an internationally recognised university. The degree must be in biochemistry/chemistry, biology, biomedicine/medicine, biotechnology, cell/molecular biology, genetics, life science, medical sciences or a similar field of study including courses in biochemistry, cell biology, chemistry, genetics, and molecular biology/-genetics of a total of at least 30 credits as well as knowledge and previous experience of related laboratory work. *Starting at the University of Groningen* A Bachelor's degree in the fields of biology, pharmacy, life science and technology or (bio)medical sciences. *Starting at Heidelberg University* A Bachelor's degree with a fixed standard period of study of at least four academic years (240 ECTS; equivalent degrees may be accepted) with above-average grades. In exceptional cases, participants of the IMIM programme may be admitted to the programme with a degree worth only 180 ECTS, provided they are able to submit proof that the outstanding 60 ECTS will be earned no later than by the end of the IMIM programme. The degree needs to be in medicine or the life sciences (e.g. biology, biochemistry, pharmaceutical sciences, biomedical sciences, genetics, molecular biology, biotechnology, health sciences or closely related fields). Proven record of academic and extra-curricular excellence as well as research experience. Strong motivation to pursue a career that incorporates translational, biomedical sciences and research. *Starting at the University of Tartu* A Bachelor's degree or equivalent qualification in the natural and exact sciences or in the field of medicine. Additionally, eligibility for IMIM and all four partner universities requires documented knowledge of English with results from an internationally accepted test. The minimum test scores are: IELTS (Academic) with an overall score of 6.5 and no less than 6.0 on each section, or Cambridge Certificate of Proficiency in English (CPE)/ Cambridge Certificate of Advanced English (CAE) with a minimum score of 180. TOEFL IBT (internet-based test) with an overall score of 92 and no less than 21 on each section.
The text is reproduced from the Susa source. Antagningsdata does not map GY11 and GY25 or assess personal eligibility.
Source, measure and data quality
- Source
- Skolverket Susa-navet
- Period
- 2026-08-19
- Measure
- Entry-requirement text reproduced from the published Susa data; no personal eligibility assessment is made.
- Population
- Education offering e.uoh.uu.mim2m.z3850.20262
- Last checked
- 2026-09-23T10:39:47.556511+00:00
- Limitation
- Antagningsdata does not map GY11 and GY25. General and specific conditions are not separated without structured source data.
Programme content
Study structure
Application and important dates
- Application deadline
- Programme or course starts
- Programme or course ends
Salary and salary distribution
Common occupations after graduation
Students
Geographical background
Previous upper-secondary schools and programmes
Completion and outcomes
About the provider
Sources and data quality
Education facts for the selected offering come from Skolverket Susa-navet.
Retrieved . Published . Times are shown in Swedish local time.
Source identity and publication version
- Publication version
- 8e217193-f5fa-4778-b085-a4521fd03e8d
- Education identity in the source
- i.uoh.uu.mim2m.z3850.20262
- Offering identity in the source
- e.uoh.uu.mim2m.z3850.20262
- Education-form source code
- HS
- Education code in the source
- MIM2M
- Change time according to the source
- 2026-07-07T13:38:03
The provider, education and education offering are separate identities. Application information should be checked on the official website. Supplementary statistics have not been obtained from this source.